40 related articles for article (PubMed ID: 25766258)
1. Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor β is associated with lymphatic metastasis in human gastric carcinoma.
Kodama M; Kitadai Y; Sumida T; Ohnishi M; Ohara E; Tanaka M; Shinagawa K; Tanaka S; Yasui W; Chayama K
Cancer Sci; 2010 Sep; 101(9):1984-9. PubMed ID: 20624165
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.
Huang QB; Ma X; Li HZ; Ai Q; Liu SW; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Zhang X
Oncotarget; 2014 May; 5(10):3066-75. PubMed ID: 24931473
[TBL] [Abstract][Full Text] [Related]
3. A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis.
Miller CP; Tsuchida C; Zheng Y; Himmelfarb J; Akilesh S
Neoplasia; 2018 Jun; 20(6):610-620. PubMed ID: 29747161
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma.
Elie BT; Hubbard K; Pechenyy Y; Layek B; Prabha S; Contel M
Cancer Med; 2019 Aug; 8(9):4304-4314. PubMed ID: 31192543
[TBL] [Abstract][Full Text] [Related]
5. Methionine secreted by tumor-associated pericytes supports cancer stem cells in clear cell renal carcinoma.
Zhang C; Du Z; Gao Y; Lim KS; Zhou W; Huang H; He H; Xiao J; Xu D; Li Q
Cell Metab; 2024 Apr; 36(4):778-792.e10. PubMed ID: 38378000
[TBL] [Abstract][Full Text] [Related]
6. [Effect of platelet derived growth factor-B and its receptor expression on the proliferation of renal cell carcinoma ACHN cells].
Wang W; Zhang Z; Wang S; Du J; Yao X
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):170-4. PubMed ID: 25975783
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma.
Kitano H; Kitadai Y; Teishima J; Yuge R; Shinmei S; Goto K; Inoue S; Hayashi T; Sentani K; Yasui W; Matsubara A
Cancer Med; 2017 Oct; 6(10):2308-2320. PubMed ID: 28834289
[TBL] [Abstract][Full Text] [Related]
8. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract][Full Text] [Related]
9. Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies.
Pathak A; Pal AK; Roy S; Nandave M; Jain K
Stem Cells Int; 2024; 2024():9077926. PubMed ID: 38213742
[TBL] [Abstract][Full Text] [Related]
10. A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer.
Zhang L; Fan S; Vera J; Lai X
Comput Struct Biotechnol J; 2023; 21():34-45. PubMed ID: 36514340
[TBL] [Abstract][Full Text] [Related]
11. The Role of PDGFRA in Predicting Oncological and Immune Characteristics in Pancreatic Ductal Adenocarcinoma.
Wu Z; Xu J; Tang R; Wang W; Zhang B; Yu X; Liu J; Shi S
J Oncol; 2022; 2022():4148805. PubMed ID: 35378770
[TBL] [Abstract][Full Text] [Related]
12. Mining Drug-Target Associations in Cancer: Analysis of Gene Expression and Drug Activity Correlations.
Arroyo MM; Berral-González A; Bueno-Fortes S; Alonso-López D; Rivas JL
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32344870
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.
Barone E; Gemignani F; Landi S
J Thorac Dis; 2018 Jan; 10(Suppl 2):S369-S382. PubMed ID: 29507807
[TBL] [Abstract][Full Text] [Related]
14. Platelet-inspired medicine for tumor therapy.
Yang J; Wang S; Liu P; Dai L; Chen B; Luan J; Zhou J
Oncotarget; 2017 Dec; 8(70):115748-115753. PubMed ID: 29383198
[TBL] [Abstract][Full Text] [Related]
15. Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics.
Oliveira RC; Ivanovic RF; Leite KRM; Viana NI; Pimenta RCA; Junior JP; Guimarães VR; Morais DR; Abe DK; Nesrallah AJ; Srougi M; Nahas W; Reis ST
BMC Urol; 2017 Dec; 17(1):113. PubMed ID: 29202733
[TBL] [Abstract][Full Text] [Related]
16. Sodium butyrate enhances the growth inhibitory effect of sunitinib in human renal cell carcinoma cells.
Sato H; Uzu M; Kashiba T; Suzuki R; Fujiwara T; Okuzawa H; Ueno K
Oncol Lett; 2017 Jul; 14(1):937-943. PubMed ID: 28693255
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape.
Farooqi AA; Siddik ZH
Cell Biochem Funct; 2015 Jul; 33(5):257-65. PubMed ID: 26153649
[TBL] [Abstract][Full Text] [Related]
18. Pericytes in sarcomas of bone.
Chang L; Nguyen V; Nguyen A; Scott MA; James AW
Med Oncol; 2015 Jul; 32(7):202. PubMed ID: 26076804
[TBL] [Abstract][Full Text] [Related]
19. Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression.
Wang W; Qi L; Tan M; Zhang Z; Du J; Wei X; Yao X
Urol Oncol; 2015 Apr; 33(4):168.e17-27. PubMed ID: 25766258
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
